Department of Internal Medicine III, RWTH University Hospital Aachen, Germany; Interdisciplinary Center for Clinical Research (IZKF), RWTH University Hospital Aachen, Germany; Center for Functionalized Magnetic Materials (FunMagMa), Immanuel Kant Baltic Federal University, Kaliningrad, Russian Federation.
Department of Internal Medicine III, RWTH University Hospital Aachen, Germany; Interdisciplinary Center for Clinical Research (IZKF), RWTH University Hospital Aachen, Germany.
J Hepatol. 2018 May;68(5):996-1005. doi: 10.1016/j.jhep.2018.01.003. Epub 2018 Jan 11.
BACKGROUND & AIMS: Heat shock protein (Hsp) 72 is a molecular chaperone that has broad cytoprotective functions and is upregulated in response to stress. To determine its hepatic functions, we studied its expression in human liver disorders and its biological significance in newly generated transgenic animals.
Double transgenic mice overexpressing Hsp72 (gene Hspa1a) under the control of a tissue-specific tetracycline-inducible system (Hsp72-LAP mice) were produced. Acute liver injury was induced by a single injection of acetaminophen (APAP). Feeding with either a methionine choline-deficient (MCD; 8 weeks) or a 3,5-diethoxycarbonyl-1,4-dihydrocollidine-supplemented diet (DDC; 12 weeks) was used to induce lipotoxic injury and Mallory-Denk body (MDB) formation, respectively. Primary hepatocytes were treated with palmitic acid.
Patients with non-alcoholic steatohepatitis and chronic hepatitis C infection displayed elevated HSP72 levels. These levels increased with the extent of hepatic inflammation and HSP72 expression was induced after treatment with either interleukin (IL)-1β or IL-6. Hsp72-LAP mice exhibited robust, hepatocyte-specific Hsp72 overexpression. Primary hepatocytes from these animals were more resistant to isolation-induced stress and Hsp72-LAP mice displayed lower levels of hepatic injury in vivo. Mice overexpressing Hsp72 had fewer APAP protein adducts and were protected from oxidative stress and APAP-/MCD-induced cell death. Hsp72-LAP mice and/or hepatocytes displayed significantly attenuated Jnk activation. Overexpression of Hsp72 did not affect steatosis or the extent of MDB formation.
Our results demonstrate that HSP72 induction occurs in human liver disease, thus, HSP72 represents an attractive therapeutic target owing to its broad hepatoprotective functions.
HSP72 constitutes a stress-inducible, protective protein. Our data demonstrate that it is upregulated in patients with chronic hepatitis C and non-alcoholic steatohepatitis. Moreover, Hsp72-overexpressing mice are protected from various forms of liver stress.
热休克蛋白(Hsp)72 是一种分子伴侣,具有广泛的细胞保护功能,并在应激反应中上调。为了确定其在肝脏中的功能,我们研究了其在人类肝脏疾病中的表达及其在新生成的转基因动物中的生物学意义。
我们制备了在组织特异性四环素诱导系统控制下过表达 Hsp72(基因 Hspa1a)的双转基因小鼠(Hsp72-LAP 小鼠)。通过单次注射对乙酰氨基酚(APAP)诱导急性肝损伤。用蛋氨酸胆碱缺乏(MCD;8 周)或 3,5-二乙氧羰基-1,4-二氢吡啶补充饮食(DDC;12 周)喂养分别诱导脂肪毒性损伤和 Mallory-Denk 体(MDB)形成。用棕榈酸处理原代肝细胞。
非酒精性脂肪性肝炎和慢性丙型肝炎感染患者的 HSP72 水平升高。这些水平随着肝炎症的程度而增加,并且在用白细胞介素(IL)-1β或 IL-6 处理后诱导 HSP72 表达。Hsp72-LAP 小鼠表现出强烈的、肝细胞特异性的 Hsp72 过表达。这些动物的原代肝细胞对分离诱导的应激更具抗性,并且 Hsp72-LAP 小鼠体内的肝损伤水平较低。过表达 Hsp72 的小鼠的 APAP 蛋白加合物较少,并且对氧化应激和 APAP-/MCD 诱导的细胞死亡有保护作用。Hsp72-LAP 小鼠和/或肝细胞的 Jnk 激活明显减弱。Hsp72 的过表达对脂肪变性或 MDB 形成的程度没有影响。
我们的结果表明,HSP72 的诱导发生在人类肝脏疾病中,因此,HSP72 因其广泛的肝保护功能而成为有吸引力的治疗靶点。
HSP72 构成一种应激诱导的保护性蛋白。我们的数据表明,它在慢性丙型肝炎和非酒精性脂肪性肝炎患者中上调。此外,过表达 Hsp72 的小鼠可免受各种形式的肝应激。